Engineered mesenchymal stem/stromal cells against cancer
Top Cited Papers
Open Access
- 19 February 2025
- journal article
- review article
- Published by Springer Nature in Cell Death & Disease
- Vol. 16 (1) , 1-12
Abstract
Mesenchymal stem/stromal cells (MSCs) have garnered attention for their potential in cancer therapy due to their ability to home to tumor sites. Engineered MSCs have been developed to deliver therapeutic proteins, microRNAs, prodrugs, chemotherapy drugs, and oncolytic viruses directly to the tumor microenvironment, with the goal of enhancing therapeutic efficacy while minimizing off-target effects. Despite promising results in preclinical studies and clinical trials, challenges such as variability in delivery efficiency and safety concerns persist. Ongoing research aims to optimize MSC-based cancer eradication and immunotherapy, enhancing their specificity and efficacy in cancer treatment. This review focuses on advancements in engineering MSCs for tumor-targeted therapy.Keywords
Funding Information
- National Natural Science Foundation of China (82202032, U24A20379, 82430086)
This publication has 143 references indexed in Scilit:
- Prodrug suicide gene therapy for cancer targeted intracellular by mesenchymal stem cell exosomesInternational Journal of Cancer, 2018
- Intratumoral Delivery of Interferonγ-Secreting Mesenchymal Stromal Cells Repolarizes Tumor-Associated Macrophages and Suppresses Neuroblastoma Proliferation In VivoStem Cells, 2018
- Combined treatment, based on lysomustine administration with mesenchymal stem cells expressing cytosine deaminase therapy, leads to pronounced murine Lewis lung carcinoma growth inhibitionThe Journal of Gene Medicine, 2016
- Targeted inhibition of osteosarcoma tumor growth by bone marrow‐derived mesenchymal stem cells expressing cytosine deaminase/5‐fluorocytosine in tumor‐bearing miceThe Journal of Gene Medicine, 2015
- Human umbilical blood mononuclear cell–derived mesenchymal stem cells serve as interleukin‐21 gene delivery vehicles for epithelial ovarian cancer therapy in nude miceBiotechnology and Applied Biochemistry, 2011
- Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosusArthritis & Rheumatism, 2010
- Direct Evidence of Mesenchymal Stem Cell Tropism for Tumor and Wounding Microenvironments Using In Vivo Bioluminescent ImagingStem Cells, 2009
- MicroRNA profiling in human medulloblastomaInternational Journal of Cancer, 2008
- Interferon beta induces interleukin‐10 expression: Relevance to multiple sclerosisAnnals of Neurology, 1996
- Mesenchymal stem cellsJournal of Orthopaedic Research, 1991